Jennifer R. Cochran - Jul 12, 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: Charles S. Berkman For: Jennifer R. Cochran
Stock symbol
LGND
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
4
Date filed
7/14/2021, 08:19 PM
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Award $0 +1.16K $0.00 1.16K Jul 12, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGND Non-Qualified Stock Option (right to buy) Award $0 +4.51K $0.00 4.51K Jul 12, 2021 Common Stock 4.51K $126.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date.